openPR Logo
Press release

Global High-Sensitivity Cardiac Biomarker Market Forecast Covering Growth Inclinations & Development Strategies until 2028 // Bio-Rad Laboratories, Enzo Life Sciences, Inc. (sub. of Enzo Biochem Inc.), Randox Laboratories Ltd, Thermo Fisher Scientific, an

03-08-2019 11:09 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Global High-Sensitivity Cardiac Biomarker Market Forecast

Many people suffer from cardiac problems, which can lead to major cardiac diseases. The use of high-sensitivity cardiac biomarkers provides real-time diagnosis for patients who are suffering from cardiac ischemia, ASC (acute coronary syndrome), and various other cardiac-related problems. The high-sensitivity cardiac biomarker is placed within the blood stream to identify the cardiac problem for checking the damage ratio of the heart, and also to find out the stress level of the heart. The diagnosis that the high-sensitivity cardiac biomarker can make determines the risk of the heart of the patient, which can be very helpful for treatment. A High-Sensitivity Cardiac Biomarker Market mostly used for the diagnosis for myoglobin, CK-MB, CK (creatinine kinase), and cardiac troponin, which can be a real-time protection for cardiac patients.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2033

The symptoms of cardiac ischemia along with acute coronary syndrome and other cardiac diseases are change in pressure, chest pain, nausea, and others, which can lead to cardiac problems. High-sensitivity cardiac biomarkers are much more effective than any other diagnosis methodology for cardiac problems. These high-sensitivity cardiac biomarkers are done at the point of care for cardiac patients.         

High-Sensitivity Cardiac Biomarker Market: Drivers and Restraints

The high-sensitivity cardiac biomarker market is expected to be a growing market over the forecast period, as the cardiac patient pool is high in various geographical regions, which directly boosts the market for high-sensitivity cardiac biomarkers. According to CDC (Centers for Disease Control and Prevention), approx. 735,000 U.S. citizens are suffer from heart attacks every year. Out of these, around 525,000 experience a first-time heart attack, and approx. 210,000 have already experienced a heart attack in the past. The developed medical systems in some of the regions also directly boosts the market for high-sensitivity cardiac biomarkers. The high cost related to high-sensitivity cardiac biomarkers along with the lack of awareness among cardiac patients and health professionals are the current hindrances for the market for high-sensitivity cardiac biomarkers.

To know more about the High-Sensitivity Cardiac Biomarker Market Visit the link- https://www.factmr.com/report/2033/high-sensitivity-cardiac-biomarker-market

The global high-sensitivity cardiac biomarker market is estimated to be a growing market, as cardiac-specialized hospitals and clinics are increasing in various regions, which directly boosts the market for high-sensitivity cardiac biomarkers. Industries along with various research organizations are working to develop new variants of high-sensitivity cardiac biomarkers that can be more accurate for monitoring cardiac problems in various age groups. Among the end users, the hospitals segment holds a major market as the presence is high all the geographical regions and also due to high budget for healthcare segment to enhance the infrastructures in developing countries.

High-Sensitivity Cardiac Biomarker Market: Regional Outlook

Geographically, the global high-sensitivity cardiac biomarker market is segmented into North America, Latin America, Europe, CIS & Russia, Japan, Asia Pacific excluding Japan (APEJ), and the Middle East & Africa (MEA). North America has a major market share, as the number of industry players present is high in the region, along with various reimbursement options, which directly affect the market for high-sensitivity cardiac biomarkers. Europe is expected to experience high growth rate, as the adoption rate for high-sensitivity cardiac biomarkers is increasing among healthcare professionals. CIS & Russia are expected to experience increasing growth, as the adoption rate is increasing among end users for high-sensitivity cardiac biomarkers. Japan is expected to experience moderate growth, as the ageing population have a high risk of cardiac problems, which directly boosts the market of high-sensitivity cardiac biomarkers. Asia Pacific excluding Japan (APEJ) is expected to experience increasing growth, as the awareness about high-sensitivity cardiac biomarkers is increasing for the diagnosis of cardiac problems, along with the increasing medical infrastructure in various countries. The Middle East & Africa (MEA) is expected to experience slow growth, as the medical infrastructure is developing in these regions, along with the increasing awareness among healthcare professionals.  

High-Sensitivity Cardiac Biomarker Market: Key Players

The global market for high-sensitivity cardiac biomarkers is highly fragmented. Examples of some of the key players operating in the global high-sensitivity cardiac biomarkers market are Creative Diagnostics, HyTest Ltd, Biomedica, Life Diagnostics, Inc., Bio-Rad Laboratories, Enzo Life Sciences, Inc. (sub. of Enzo Biochem Inc.), Randox Laboratories Ltd, Thermo Fisher Scientific, and Merck KGaA, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2033

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://theswisstimes.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global High-Sensitivity Cardiac Biomarker Market Forecast Covering Growth Inclinations & Development Strategies until 2028 // Bio-Rad Laboratories, Enzo Life Sciences, Inc. (sub. of Enzo Biochem Inc.), Randox Laboratories Ltd, Thermo Fisher Scientific, an here

News-ID: 1641958 • Views: 1023

More Releases from Fact.MR

07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fact.MR
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
03-20-2020 | Health & Medicine
Fact.MR
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases


More Releases for Cardiac

Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are